Drug intelligence / Profile preview

cannflavin a + cannflavin b

Development stage: Preclinical
Lead developer: Delica
Modality: Small Molecules

Overview

Cannflavins A + Cannflavins B is a preclinical small molecule combination therapy being developed by Delica Therapeutics. The active ingredients are non-psychoactive prenylated flavonoids derived from *Cannabis sativa L.*, which are chemically distinct from cannabinoids like THC. The drug acts as a potent anti-inflammatory agent by inhibiting prostaglandin E2 (PGE2) synthesis and 5-lipoxygenase (5-LOX), reportedly exhibiting potency approximately 30 times greater than aspirin by weight. Delica is investigating the compound for primary indications in inflammation and neuroprotection, with additional research exploring its potential in neurodegenerative diseases, oncology, and infectious diseases.

Other names: Cannflavins A & BCFL-A + CFL-BCannflavin A + Cannflavin B

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)PTGES (Microsomal prostaglandin E synthase-1)

Beyond the preview

Go deeper on cannflavin a + cannflavin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cannflavin a + cannflavin b.

Explore the full profile